Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genpact LTDG · Entity 3760 | Director | February 18, 2025 | February 20, 2025 |
| JABIL INCJBL · Entity 3138 | Director | July 17, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genpact LTD
Report date February 18, 2025 · Filed February 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 604,631 |
Reported balance
After 2025-02-18 transaction · row 1
1 source rowRow 1 · 2025-02-18 · Sale · Disposed 108,880 · Balance 604,631 F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $54.62 to $55.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 5,300 |
Reported balance
Holding disclosure · report date 2025-02-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,300 F2: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $54.62 to $55.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
JABIL INC
Report date July 17, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,464 |
Reported balance
After 2026-07-17 transaction · row 1
1 source rowRow 1 · 2026-07-17 · Purchase · Acquired 500 · Balance 3,464 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2017 Filed Mar 10, 2017 21:15 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 155,413 | $24.09 | $3,744,598.53 |
DisclosureSEC source: 0001140361-17-011622 · doc1.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,374 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $24.045 to $24.155. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 21:15 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 155,413 | $14.22 | $2,209,693.12 |
DisclosureSEC source: 0001140361-17-011622 · doc1.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:42 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $14.22 | $0.00 |
DisclosureSEC source: 0001140361-17-004900 · doc1.xml · derivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,642 Underlying: Common Shares · 75,000 shares Expires 2017-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 33% on December 31, 2010 and each anniversary thereof. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:42 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 75,000 | $25.00 | $1,875,082.50 |
DisclosureSEC source: 0001140361-17-004900 · doc1.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,374 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $25.00 to $25.005. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:42 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 75,000 | $14.22 | $1,066,365.00 |
DisclosureSEC source: 0001140361-17-004900 · doc1.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:21 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 16,233 | $24.34 | $395,111.22 |
DisclosureSEC source: 0001140361-17-000397 · doc1.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,374 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2007 Omnibus Incentive Compensation Plan. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:44 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 36,820 | $0.00 Strike: $14.22 | $0.00 |
DisclosureSEC source: 0001140361-16-090260 · doc1.xml · derivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,642 Underlying: Common Shares · 36,820 shares Expires 2017-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 33% on December 31, 2010 and each anniversary thereof. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:44 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 36,820 | $24.20 | $891,183.92 |
DisclosureSEC source: 0001140361-16-090260 · doc1.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,607 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $24.15 to $24.25. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:44 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 36,820 | $14.22 | $523,514.12 |
DisclosureSEC source: 0001140361-16-090260 · doc1.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.